Development of a tool to measure patient-oriented outcomes for Veterans with inflammatory arthritis initiating self-administered biologic therapies.
- 1University of Wisconsin-Madison School of Pharmacy, 777 Highland Ave, Madison, WI 53705, United States of America.
- 2William S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, United States of America.
- 3University of Michigan College of Pharmacy, 428 Church St, Ann Arbor, MI 48109, United States of America.
Abstract
Veterans Health Administration Centralized Specialty Medication Management (CSMM) clinics have positive financial and process outcomes but lack patient-oriented outcomes. This project developed a tool to evaluate patient-oriented outcomes among Veterans with inflammatory arthritis and/or psoriasis initiating biologic therapies. Using validated questionnaires, a tool was constructed and piloted. Four rounds of cognitive interviews, with 2 Veterans each, were conducted. Pre- and post-CSMM clinic cognitive interviews were conducted with 2 Veterans initiating biologic therapy. The tool was piloted with patients initiating biologic therapy. The post-CSMM survey began with 55 questions. There was 1 pilot interview for readability, 8 cognitive interviews over 4 tool versions, and 2 pre- post-CSMM survey cognitive interviews; 18 questions were revised, 9 removed, and 7 added. No problematic questions were identified during the final cognitive interviews. In pre- post-CSMM cognitive interviews, no problematic questions were identified and both Veterans endorsed connection of the pre- and post-questions. The final post-CSMM survey had 53 questions and the pre-CSMM survey had 31 questions. In the pilot, the pre- and post-CSMM survey was administered to 23 Veterans. Between interviews 34 days and 1.7 CSMM appointments elapsed. Time to complete the pre-CSMM survey and post-CSMM survey was 21 and 26 min, respectively. There were no difficult or confusing questions identified in the pilot. This project created a pre- and post-CSMM tool with high content validity to measure patient-oriented outcomes among Veterans with inflammatory arthritis and/or psoriasis initiating biologic therapy. Feasibility in conducting pre- and post-CSMM interviews using the tool was established.
Related
- Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy
- Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: Results from the MAJIK-SFR registry
- Advanced drug delivery and PBPK modelling as translational tools for precision therapies in juvenile idiopathic arthritis
- Editorial: Exploring the impact of inflammatory processes on the course of acute myocardial infarction: pathways and therapies
- Development and evaluation of a nurse-administered triage questionnaire for ophthalmic emergencies during on-call hours: A multicenter retrospective study
BibTeX
@article{margolis2026development,
title = {{Development of a tool to measure patient-oriented outcomes for Veterans with inflammatory arthritis initiating self-administered biologic therapies.}},
author = {Amanda Margolis and Clara Nickel and Olayinka Shiyanbola and Nicholas Apitz and Grayson Cooley and Betty Chewning},
journal = {Exploratory research in clinical and social pharmacy},
year = {2026},
month = oct,
doi = {10.1016/j.rcsop.2026.100857},
url = {https://europepmc.org/article/MED/42999443},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Development of a tool to measure patient-oriented outcomes for Veterans with inflammatory arthritis initiating self-administered biologic therapies.
AU - Amanda Margolis
AU - Clara Nickel
AU - Olayinka Shiyanbola
AU - Nicholas Apitz
AU - Grayson Cooley
AU - Betty Chewning
PY - 2026
DA - 2026/10/03
JO - Exploratory research in clinical and social pharmacy
DO - 10.1016/j.rcsop.2026.100857
UR - https://europepmc.org/article/MED/42999443
AB - Veterans Health Administration Centralized Specialty Medication Management (CSMM) clinics have positive financial and process outcomes but lack patient-oriented outcomes. This project developed a tool to evaluate patient-oriented outcomes among Veterans with inflammatory arthritis and/or psoriasis initiating biologic therapies. Using validated questionnaires, a tool was constructed and piloted. Four rounds of cognitive interviews, with 2 Veterans each, were conducted. Pre- and post-CSMM clinic cognitive interviews were conducted with 2 Veterans initiating biologic therapy. The tool was piloted with patients initiating biologic therapy. The post-CSMM survey began with 55 questions. There was 1 pilot interview for readability, 8 cognitive interviews over 4 tool versions, and 2 pre- post-CSMM survey cognitive interviews; 18 questions were revised, 9 removed, and 7 added. No problematic questions were identified during the final cognitive interviews. In pre- post-CSMM cognitive interviews, no problematic questions were identified and both Veterans endorsed connection of the pre- and post-questions. The final post-CSMM survey had 53 questions and the pre-CSMM survey had 31 questions. In the pilot, the pre- and post-CSMM survey was administered to 23 Veterans. Between interviews 34 days and 1.7 CSMM appointments elapsed. Time to complete the pre-CSMM survey and post-CSMM survey was 21 and 26 min, respectively. There were no difficult or confusing questions identified in the pilot. This project created a pre- and post-CSMM tool with high content validity to measure patient-oriented outcomes among Veterans with inflammatory arthritis and/or psoriasis initiating biologic therapy. Feasibility in conducting pre- and post-CSMM interviews using the tool was established.
SN - 2667-2766
ER -